2 results match your criteria: "Dr. Aher's Neocare Hospital[Affiliation]"
Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
Cochrane Database Syst Rev
April 2014
Neonatology, Dr. Aher's Neocare Hospital, Near Tusakhre Lawns, Mumbai Naka, Nashik, Maharashtra, India, 422002.
Background: Low plasma levels of erythropoietin (EPO) in preterm infants provide a rationale for the use of EPO to prevent or treat anaemia.
Objectives: To assess the effectiveness and safety of late initiation of erythropoietin (EPO) between eight and 28 days after birth, in reducing the use of red blood cell (RBC) transfusions in preterm and/or low birth weight infants.
Search Methods: We searched the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE, EMBASE, and CINAHL in July 2013.
Early versus late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
Cochrane Database Syst Rev
October 2012
Neonatology, Dr. Aher’s Neocare Hospital, Nashik, India.
Background: Low plasma levels of erythropoietin (EPO) in preterm infants provide a rationale for the use of EPO to prevent or treat anaemia.
Objectives: To assess the effectiveness and safety of early versus late initiation of EPO in reducing red blood cell (RBC) transfusions in preterm and/or low birth weight (LBW) infants.
Search Methods: The standard search of the Cochrane Neonatal Review Group (CNRG) was performed in 2006 and updated in 2009.